Stock P09 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Pacific Biosciences of California, Inc. BOERSE MUENCHEN

Equities

P09

US69404D1081

Market Closed - BOERSE MUENCHEN
Other stock markets
 20:43:05 05/07/2024 BST 		After market 21:00:09
1.199 EUR -3.56% Intraday chart for Pacific Biosciences of California, Inc. 1.204 +0.45%
07-01 Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 3000E Growth Index CI
07-01 Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2000 Growth Index CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry
MT
Form Bio and Pacbio Announce Collaboration to Launch New Resources Set to Transform Aav Design and Analysis Best Practices
CI
PacBio and International Research Consortium Colors Announce Release of First-Ever HiFi Long-Read Variant Database
CI
Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes
MT
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
CI
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M
MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sector Update: Health Care Stocks Higher Late Afternoon
MT
Sector Update: Health Care
MT
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink
MT
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024
CI
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
CI
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions
CI
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours
MT
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q4 Revenue $58.4M, vs. Street Est of $58.3M
MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
CI
PacBio Announces New Nanobind Pandna Kit Enabling Hifi Optimized Dna Extraction Solutions
CI
Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue
MT
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. P09 Stock
  5. News Pacific Biosciences of California, Inc.
  6. Highlights